CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer

Purpose Resident memory CD8 T cells, owing to their ability to reside and persist in peripheral tissues, impart adaptive sentinel activity and amplify local immune response, and have beneficial implications for tumor surveillance and control. The current study aimed to clarify the less known chemotactic mechanisms that govern the localization, retention, and residency of memory CD8 T cells in the ovarian tumor microenvironment. Experimental design RNA and protein expressions of chemokine receptors in CD8+ resident memory T cells in human ovarian tumor-infiltrating CD8+ T cells and their association with survival were analyzed. The role of CXCR6 on antitumor T cells was investigated using prophylactic vaccine models in murine ovarian cancer. Results Chemokine receptor profiling of CD8+CD103+ resident memory tumor-infiltrating lymphocytes in patients with ovarian cancer revealed high expression of CXCR6. Analysis of The Cancer Genome Atlas (TCGA) (ovarian cancer database revealed CXCR6 to be associated with CD103 and increased patient survival. Functional studies in mouse models of ovarian cancer revealed that CXCR6 is a marker of resident, but not circulatory, tumor-specific memory CD8+ T cells. CXCR6-deficient tumor-specific CD8+ T cells showed reduced retention in tumor tissues, leading to diminished resident memory responses and poor control of ovarian cancer. Conclusions CXCR6, by promoting retention in tumor tissues, serves a critical role in resident memory T cell-mediated immunosurveillance and control of ovarian cancer. Future studies warrant exploiting CXCR6 to promote resident memory responses in cancers.

[1]  A. Vincent-Salomon,et al.  Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells , 2020, Immunity.

[2]  Kouji Matsushima,et al.  CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways , 2019, The Journal of experimental medicine.

[3]  S. Jameson,et al.  The Functional Requirement for CD69 in Establishment of Resident Memory CD8+ T Cells Varies with Tissue Location , 2019, The Journal of Immunology.

[4]  M. Seshadri,et al.  Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer , 2019, Journal of Immunotherapy for Cancer.

[5]  E. King,et al.  Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer , 2019, The Journal of experimental medicine.

[6]  D. Masopust,et al.  Tissue-Resident T Cells and Other Resident Leukocytes. , 2019, Annual review of immunology.

[7]  Scott N. Mueller,et al.  Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin , 2018, Nature.

[8]  T. Schumacher,et al.  Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers , 2018, Nature Medicine.

[9]  E. Tartour,et al.  Targeting Resident Memory T Cells for Cancer Immunotherapy , 2018, Front. Immunol..

[10]  B. Fox,et al.  Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors , 2018, Nature Communications.

[11]  R. V. van Lier,et al.  Tissue-resident memory T cells at the center of immunity to solid tumors , 2018, Nature Immunology.

[12]  M. Fehlings,et al.  Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates , 2018, Nature.

[13]  A. Goldrath,et al.  Transcriptional programming of tissue-resident memory CD8+ T cells. , 2018, Current opinion in immunology.

[14]  N. Maugeri,et al.  The Neutrophil’s Choice: Phagocytose vs Make Neutrophil Extracellular Traps , 2018, Front. Immunol..

[15]  Scott N. Mueller,et al.  Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses , 2018, Nature Immunology.

[16]  Wei Wang,et al.  Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumors , 2017, Nature.

[17]  Scott N. Mueller,et al.  Chemokine Receptor–Dependent Control of Skin Tissue–Resident Memory T Cell Formation , 2017, The Journal of Immunology.

[18]  I. Melero,et al.  Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells , 2017, Nature Communications.

[19]  E. King,et al.  Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer , 2017, Nature Immunology.

[20]  Peisheng Zhang,et al.  Resident memory T cells in the skin mediate durable immunity to melanoma , 2017, Science Immunology.

[21]  P. Fink,et al.  Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue-Resident Memory T Cells. , 2017, Cell reports.

[22]  X. Deupí,et al.  The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion , 2017, PloS one.

[23]  P. Puigserver,et al.  Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism , 2017, Nature.

[24]  Chiara Bonini,et al.  T memory stem cells in health and disease , 2017, Nature Medicine.

[25]  K. Odunsi,et al.  Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer , 2016, Oncoimmunology.

[26]  N. McGovern,et al.  A High-Dimensional Atlas of Human T Cell Diversity Reveals Tissue-Specific Trafficking and Cytokine Signatures. , 2016, Immunity.

[27]  W. Shi,et al.  Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes , 2016, Science.

[28]  Scott N. Mueller,et al.  Tissue-resident memory T cells: local specialists in immune defence , 2015, Nature Reviews Immunology.

[29]  D. Pellicci,et al.  T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate. , 2015, Immunity.

[30]  Fadi G Lakkis,et al.  Memory T Cell Migration , 2015, Front. Immunol..

[31]  K. Odunsi,et al.  LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model , 2015, Oncotarget.

[32]  K. Odunsi,et al.  Non-redundant Requirement for CXCR3 Signaling during Tumoricidal T Cell Trafficking across Tumor Vascular Checkpoints , 2015, Nature Communications.

[33]  B. Nelson,et al.  PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer , 2015, Cancer Immunology Research.

[34]  J. Schenkel,et al.  Tissue-resident memory T cells. , 2014, Immunity.

[35]  Andrea J. Radtke,et al.  The chemokine receptor CXCR6 is required for the maintenance of liver memory CD8⁺ T cells specific for infectious pathogens. , 2014, The Journal of infectious diseases.

[36]  Ji-Ying Song,et al.  Skin-resident memory CD8+ T cells trigger a state of tissue-wide pathogen alert , 2014, Science.

[37]  J. Schenkel,et al.  Resident memory CD8 T cells trigger protective innate and adaptive immune responses , 2014, Science.

[38]  Liang Zhang,et al.  Maraba virus as a potent oncolytic vaccine vector. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  Scott N. Mueller,et al.  The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin , 2013, Nature Immunology.

[40]  M. Bevan,et al.  Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. , 2013, Immunity.

[41]  Thomas Gebhardt,et al.  Memory T cell subsets, migration patterns, and tissue residence. , 2013, Annual review of immunology.

[42]  B. Nelson,et al.  Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer. , 2010, Gynecologic oncology.

[43]  H. Atkins,et al.  Identification of genetically modified Maraba virus as an oncolytic rhabdovirus. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  Thomas Gebhardt,et al.  Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus , 2009, Nature Immunology.

[45]  Gerd Ritter,et al.  Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Rose-John,et al.  The Transmembrane CXC-Chemokine Ligand 16 Is Induced by IFN-γ and TNF-α and Shed by the Activity of the Disintegrin-Like Metalloproteinase ADAM10 1 , 2004, The Journal of Immunology.

[47]  R. Rabin,et al.  CXCR3 Is Induced Early on the Pathway of CD4+ T Cell Differentiation and Bridges Central and Peripheral Functions 12 , 2003, The Journal of Immunology.

[48]  George Coukos,et al.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.

[49]  Sharon Engel,et al.  A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.

[50]  J L Pace,et al.  Development of a syngeneic mouse model for events related to ovarian cancer. , 2000, Carcinogenesis.

[51]  A. Luster,et al.  Chemokines: Critical Regulators of Memory T Cell Development, Maintenance, and Function. , 2018, Advances in immunology.

[52]  Andrea J. Radtke,et al.  The Chemokine Receptor CXCR 6 Is Required for the Maintenance of Liver Memory CD 8 + T Cells Speci fi c for Infectious Pathogens , 2014 .